1.1 Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth

1.2 The Strategic Imperative 8™

1.3 The Impact of the Top Three Strategic Imperatives on the Digital Therapeutic Industry

1.4 Growth Opportunities Fuel the Growth Pipeline Engine™

2.1 Research Scope and Key Questions the Study Will Answer

2.2 Research Methodology

2.3 Key Findings

3.1 Digital Therapeutics to Decentralize Healthcare Delivery and Improve Outcomes

3.2 AI and Personalization of Digital Therapeutics

3.3 Benefits of Digital Therapeutics Across the Healthcare Value Chain

3.4 Key Applications or Indications Treated Using Digital Therapeutics

3.5 Approved Digital Therapeutics Across Indications

3.6 Clinical Trial Analysis of Digital Therapeutic Industry

3.7 Impact of COVID-19 on Digital Therapy Adoption

4.1 Digital Therapy in Cancer Pharmacotherapy

4.2 Digital Therapeutics Improving Oncology Therapy Outcomes

4.3 Rising Partnership with Pharmaceutical Companies

4.4 Digital Therapy to Treat Anxiety and Depression Related to Cancer

5.1 Digital Therapy for Treating Motor- and Nonmotor Symptoms of Neurodegenerative Diseases

5.2 Digital Therapy Improving Cognitive Functioning, and Mental Health

5.3 Digital Therapeutics R&D for Neurodegenerative Diseases

6.1 Digital Therapeutics Democratizing Physical Therapy

6.2 Digital Physical Therapy Offering Tailored Therapies and Improved Engagement

6.3 Accelerated R&D and Commercialization for Physical Digital Therapeutics

7.1 Voluntis, France

7.2 Kaiku Health (a part of Elekta), Finland

7.3 Prosoma, UK

7.4 NeuroGlee Therapeutics, Singapore

7.5 Cognito Therapeutics, US

7.6 Kaia Health

8.1 Growing Numbers of Patent Published for Digital Therapy

8.2 Record Patent Publication in US and EU Jurisdiction

8.3 Key Patents for Digital Therapeutics for Treatment of Cancer and Neurodegenerative Diseases, 2021

9.1 Growth Opportunity 1: Healthcare Interoperability for Predictive Digital Care

9.1 Growth Opportunity 1: Healthcare Interoperability for Predictive Digital Care (continued)

9.2 Growth Opportunity 2: A Combination of Digital and Pharmacotherapy for Improved Health Outcomes

9.2 Growth Opportunity 2: A Combination of Digital and Pharmacotherapy for Improved Health Outcomes (continued)

9.3 Growth Opportunity 3: Outcome-based Healthcare Contract for Greater Uptake

9.3 Growth Opportunity 3: Outcome-based Healthcare Contract for Greater Uptake (continued)

10.1 Key Industry Participants

11.1 Your Next Steps

11.2 Why Frost, Why Now?

Legal Disclaimer